ALLR
Price:
$3.3899
Market Cap:
$4.79M
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 cli...[Read more]
Industry
Biotechnology
IPO Date
2021-12-21
Stock Exchange
NASDAQ
Ticker
ALLR
According to Allarity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -704.78%. This represents a change of -1113.79% compared to the average of 69.52% of the last 4 quarters.
The mean historical ROE of Allarity Therapeutics, Inc. over the last ten years is -131.48%. The current -704.78% ROE has changed 436.04% with respect to the historical average. Over the past ten years (40 quarters), ALLR's ROE was at its highest in in the March 2023 quarter at 926.55%. The ROE was at its lowest in in the December 2022 quarter at -150.16%.
Average
-131.48%
Median
-79.62%
Minimum
-849.63%
Maximum
432.61%
Discovering the peaks and valleys of Allarity Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 650.88%
Maximum Annual ROE = 432.61%
Minimum Annual Increase = -150.92%
Minimum Annual ROE = -849.63%
Year | ROE | Change |
---|---|---|
2023 | 432.61% | -150.92% |
2022 | -849.63% | 498.90% |
2021 | -141.87% | 650.88% |
2020 | -18.89% | -76.27% |
The current ROE of Allarity Therapeutics, Inc. (ALLR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-186.30%
5-year avg
-131.48%
10-year avg
-131.48%
Allarity Therapeutics, Inc.’s ROE is greater than Immix Biopharma, Inc. (-86.48%), less than CNS Pharmaceuticals, Inc. (428.91%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Navidea Biopharmaceuticals, Inc. (-63.06%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Virios Therapeutics, Inc. (-130.35%), greater than Zura Bio Limited (-35.45%), greater than ZyVersa Therapeutics, Inc. (-172.51%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), less than Kiromic BioPharma, Inc. (337.72%), greater than Virax Biolabs Group Limited (-115.10%), greater than Biodexa Pharmaceuticals Plc (-141.90%), less than Apexigen, Inc. (0%), greater than Phio Pharmaceuticals Corp. (-606.56%), greater than null (-142.68%),
Company | ROE | Market cap |
---|---|---|
-86.48% | $50.78M | |
428.91% | $4.78M | |
2.18% | $223.46K | |
-63.06% | $100.08K | |
-398.33% | $4.46M | |
-130.35% | $5.44M | |
-35.45% | $228.63M | |
-172.51% | $2.52M | |
-112.11% | $2.51M | |
337.72% | $2.78M | |
-115.10% | $12.31M | |
-141.90% | $103.47K | |
0% | $9.57M | |
-606.56% | $2.79M | |
-142.68% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allarity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Allarity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Allarity Therapeutics, Inc.'s ROE?
How is the ROE calculated for Allarity Therapeutics, Inc. (ALLR)?
What is the highest ROE for Allarity Therapeutics, Inc. (ALLR)?
What is the 3-year average ROE for Allarity Therapeutics, Inc. (ALLR)?
What is the 5-year average ROE for Allarity Therapeutics, Inc. (ALLR)?
How does the current ROE for Allarity Therapeutics, Inc. (ALLR) compare to its historical average?